{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:33:03Z","timestamp":1778286783355,"version":"3.51.4"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Esophageal squamous cell carcinoma (ESCC) is highly prevalent in Asian populations and carries a poor prognosis. With growing numbers of cancer survivors, the prognostic impact of prior cancer in ESCC remains unclear. Most existing data are derived from Western cohorts dominated by adenocarcinoma, limiting generalizability to Asian populations.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate whether prior cancer is associated with overall survival (OS) and esophageal cancer\u2013specific mortality (ECSM) in a nationwide Korean ESCC cohort.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A retrospective cohort study of patients with newly diagnosed ESCC across 19 tertiary hospitals in Korea from 2005 to 2017 was conducted. Follow-up was completed in 2017. Data were reanalyzed in August 2025. Exclusion criteria were nonsquamous histology (including adenocarcinoma), diagnosis of esophageal cancer within 6 months of a prior cancer, multiple prior cancers, and hematologic cancers.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n History of cancer before the diagnosis of ESCC, classified by cancer type and latency (\u22645 years vs &amp;gt;5 years).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was OS, and the secondary outcome was esophageal cancer\u2013specific mortality (ECSM). Hazard ratios (HRs) and cause-specific hazard ratios (CSHRs) were estimated after adjustment for clinicopathologic and treatment variables. Propensity score\u2013adjusted Cox regression and competing risk regression models were used. Subgroup analyses were conducted by prior cancer type and latency period.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of the 5557 patients (mean [SD] age, 64.7 [8.9] years; 5168 [93.0%] male), 368 (6.6%) had a prior cancer and were older and more often diagnosed at an earlier stage than those without prior cancer. Patients with a prior cancer had significantly poorer outcomes, with a median OS of 3.58 (95% CI, 2.50\u20134.92) vs 4.25 (95% CI, 3.83\u20134.58) years and a 3-year ECSM of 8.35% (95% CI, 4.42%-12.29%) vs 4.98% (95% CI, 4.17%-5.78%) compared with those without a prior cancer. Prior cancer was independently associated with worse OS (HR, 1.25; 95% CI, 1.07\u20131.47) and ECSM (CSHR, 1.89; 95% CI, 1.09\u20133.29). Among prior cancer types, patients with a history of stomach, head and neck, or lung cancer demonstrated poorer OS (HR, 1.63; 95% CI, 1.24-2.15;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). A latency of 5 or more years was also associated with reduced OS (HR, 1.27; 95% CI, 1.03\u20131.57;\n P<\/jats:italic>\n \u2009=\u2009.02).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this nationwide Korean cohort study, prior cancer was an independent adverse prognostic factor in ESCC, with stomach, head and neck, and lung cancers associated with the poorest outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.60193","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:30:30Z","timestamp":1771605030000},"page":"e2560193","source":"Crossref","is-referenced-by-count":1,"title":["Prior Cancer and Survival in Patients With Esophageal Squamous Cell Carcinoma"],"prefix":"10.1001","volume":"9","author":[{"given":"Suna","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Taek","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Kyung","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Ah","family":"Lee","sequence":"additional","affiliation":[{"name":"Clinical Trial Center, Ewha Womans University Mokdong Hospital, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Sun","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kee","family":"Don Choi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwoon-Yong","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Chul","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong Goo","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Jin","family":"Hong","sequence":"additional","affiliation":[{"name":"Digestive Disease Center and Research Institute, Soonchunhyang University College of Medicine, Bucheon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaekyu","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Chul","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, St. Vincent Hospital, The Catholic University of Korea, Suwon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Korea University Ansan Hospital, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Ho","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Internal Medicine, Konyang University Hospital, Daejeon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Sik","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Keimyung University College of Medicine, Daegu, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Woo","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Seung","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Digestive Disease Research Institute, Wonkwang University School of Medicine, Iksan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ok-Jae","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gyeongsang National University College of Medicine and Institute of Medical Sciences, Gyeongsang National University, Jinju, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwang Ho","family":"Baik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"Wonkwang Digestive Disease Research Institute, Gunpo, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"30","key":"zoi251609r1","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1200\/JCO.2012.41.8681","article-title":"Second malignant neoplasms: assessment and strategies for risk reduction.","volume":"30","author":"Wood","year":"2012","journal-title":"J Clin Oncol"},{"key":"zoi251609r2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2407-11-83","article-title":"The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study.","volume":"11","author":"Youlden","year":"2011","journal-title":"BMC Cancer"},{"issue":"4","key":"zoi251609r4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study.","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"zoi251609r5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021.","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"zoi251609r6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13402-019-00488-2","article-title":"Esophageal carcinoma: towards targeted therapies.","volume":"43","author":"Fatehi Hassanabad","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"zoi251609r7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2217\/imt-2019-0153","article-title":"Immunotherapy for esophageal cancer: a 2019 update.","volume":"12","author":"Schizas","year":"2020","journal-title":"Immunotherapy"},{"issue":"2","key":"zoi251609r8","first-page":"189","article-title":"Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.","volume":"7","author":"Hyder","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"7","key":"zoi251609r9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024798","article-title":"Survival outcomes in esophageal cancer patients with a prior cancer.","volume":"100","author":"Pan","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"zoi251609r10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.21037\/jtd-21-1707","article-title":"Effect of prior cancer history on survival of patients with esophageal carcinoma: a propensity score matching, population-based study.","volume":"14","author":"Liu","year":"2022","journal-title":"J Thorac Dis"},{"issue":"1","key":"zoi251609r11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00268-004-7542-x","article-title":"Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma.","volume":"29","author":"Mariette","year":"2005","journal-title":"World J Surg"},{"issue":"20","key":"zoi251609r12","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"zoi251609r13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2125.1994.tb05705.x","article-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).","volume":"37","author":"Baber","year":"1994","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"zoi251609r15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1442-2050.2012.01437.x","article-title":"Tag single nucleotide polymorphisms of alcohol-metabolizing enzymes modify the risk of upper aerodigestive tract cancers: HapMap database analysis.","volume":"27","author":"Chung","year":"2014","journal-title":"Dis Esophagus"},{"issue":"3","key":"zoi251609r16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ijc.20619","article-title":"Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan.","volume":"113","author":"Lee","year":"2005","journal-title":"Int J Cancer"},{"issue":"7","key":"zoi251609r17","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1245\/s10434-010-1024-1","article-title":"7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.","volume":"17","author":"Rice","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"zoi251609r18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"5","key":"zoi251609r19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/00207454.2018.1538989","article-title":"Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.","volume":"129","author":"Al-Husseini","year":"2019","journal-title":"Int J Neurosci"},{"issue":"2","key":"zoi251609r20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4143\/crt.2019.210","article-title":"Impact of prior cancer history on the clinical outcomes in advanced breast cancer: a propensity score-adjusted, population-based study.","volume":"52","author":"Lin","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"4","key":"zoi251609r21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv002","article-title":"Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.","volume":"107","author":"Laccetti","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi251609r22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12885-019-5744-8","article-title":"Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis.","volume":"19","author":"He","year":"2019","journal-title":"BMC Cancer"},{"key":"zoi251609r23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.oraloncology.2019.01.023","article-title":"Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.","volume":"90","author":"Wang","year":"2019","journal-title":"Oral Oncol"},{"issue":"1","key":"zoi251609r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103235","article-title":"Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.","volume":"43","author":"Wang","year":"2022","journal-title":"Am J Otolaryngol"},{"issue":"7636","key":"zoi251609r25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma.","volume":"541","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Nature"},{"issue":"9","key":"zoi251609r26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.31083\/j.fbl2809219","article-title":"TP53 Mutations in Esophageal Squamous Cell Carcinoma.","volume":"28","author":"Zhong","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"43","key":"zoi251609r27","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.3748\/wjg.v12.i43.6933","article-title":"Methylation in esophageal carcinogenesis.","volume":"12","author":"Wu","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"3","key":"zoi251609r28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/cncr.21657","article-title":"CpG island hypermethylation in progression of esophageal and gastric cancer.","volume":"106","author":"Sato","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"zoi251609r29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2012.02.036","article-title":"Epigenetic biomarkers in esophageal cancer.","volume":"342","author":"Kaz","year":"2014","journal-title":"Cancer Lett"},{"issue":"3","key":"zoi251609r30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00441-014-1876-y","article-title":"Epigenetics in esophageal cancers.","volume":"356","author":"Ahrens","year":"2014","journal-title":"Cell Tissue Res"},{"key":"zoi251609r31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.549850","article-title":"Aberrant DNA methylation in esophageal squamous cell carcinoma: biological and clinical implications.","volume":"10","author":"Lin","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"zoi251609r32","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/carcin\/bgg062","article-title":"Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.","volume":"24","author":"Zhang","year":"2003","journal-title":"Carcinogenesis"},{"issue":"5","key":"zoi251609r33","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.21037\/tcr-20-2880","article-title":"Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma.","volume":"10","author":"Wang","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"6","key":"zoi251609r34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1158\/1055-9965.EPI-07-2876","article-title":"Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.","volume":"17","author":"Chuang","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"zoi251609r35","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0003-4975(98)00177-5","article-title":"Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications.","volume":"65","author":"Poon","year":"1998","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"zoi251609r36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1442-2050.2000.00116.x","article-title":"Multiple primary malignant neoplasms in patients with esophageal cancer.","volume":"13","author":"Nagasawa","year":"2000","journal-title":"Dis Esophagus"},{"issue":"23","key":"zoi251609r37","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1200\/JCO.2003.12.074","article-title":"Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.","volume":"21","author":"Matsubara","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi251609r38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a117689","article-title":"Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.","volume":"142","author":"Begg","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"5","key":"zoi251609r39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"issue":"1","key":"zoi251609r40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00432-010-0865-0","article-title":"Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site.","volume":"137","author":"Chen","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"zoi251609r41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0929-6646(10)60072-1","article-title":"Secondary prevention of esophageal squamous cell carcinoma in areas where smoking, alcohol, and betel quid chewing are prevalent.","volume":"109","author":"Chung","year":"2010","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"zoi251609r42","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.23798","article-title":"Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.","volume":"123","author":"Chuang","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"zoi251609r43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","article-title":"Japanese gastric cancer treatment guidelines 2014 (ver. 4).","volume":"20","author":"Japanese Gastric Cancer Association","year":"2017","journal-title":"Gastric Cancer"},{"issue":"11","key":"zoi251609r44","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1245\/s10434-020-08517-3","article-title":"Surveillance endoscopy guidelines for postgastrectomy patients based on risk of developing remnant gastric cancer.","volume":"27","author":"Han","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"zoi251609r45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/CLEP.S304332","article-title":"Second primary cancers after gastric cancer, and gastric cancer as second primary cancer.","volume":"13","author":"Zheng","year":"2021","journal-title":"Clin Epidemiol"},{"issue":"Pt A","key":"zoi251609r46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canep.2017.08.007","article-title":"Risk of second primary cancers among patients with a first primary gastric cancer: a population-based study in North Portugal.","volume":"50","author":"Morais","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"zoi251609r47","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.906125","article-title":"Endoscopic screening for second primary tumors of the esophagus among head and neck cancer patients.","volume":"12","author":"Chung","year":"2022","journal-title":"Front Oncol"},{"key":"zoi251609r48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oraloncology.2019.06.038","article-title":"Clinical benefits from endoscopy screening of esophageal second primary tumor for head and neck cancer patients: analysis of a hospital-based registry.","volume":"96","author":"Chung","year":"2019","journal-title":"Oral Oncol"},{"key":"zoi251609r49","doi-asserted-by":"crossref","first-page":"E2343","DOI":"10.1002\/hed.24277","article-title":"Image-enhanced endoscopy for detection of second primary neoplasm in patients with esophageal and head and neck cancer: A systematic review and meta-analysis.","volume":"38","author":"Chung","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"zoi251609r50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12885-020-6558-4","article-title":"Superiority of NBI endoscopy to PET\/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis.","volume":"20","author":"Su","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"zoi251609r51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/cam4.2688","article-title":"Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis.","volume":"9","author":"Mitani","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"zoi251609r52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/CNQ.0000000000000295","article-title":"Lifestyle risk factors in esophageal cancer: an integrative review.","volume":"43","author":"Zhao","year":"2020","journal-title":"Crit Care Nurs Q"},{"key":"zoi251609r3","volume-title":"World Cancer Report: Cancer Research for Cancer Prevention","author":"World","year":"2020"},{"key":"zoi251609r14","volume-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10)","author":"World Health Organization","year":"2016","edition":"5th ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2845322\/yu_2026_oi_251609_1772648312.87861.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:30:25Z","timestamp":1772649025000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2845322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.60193","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}